A bi-parametric model for the tumour angiogenesis and antiangiogenesis therapy

Mathematical and Computer Modelling

Volumn 49, Issue 5-6, 2009, Pages 1156-1163

  d'Onofrio, Alberto ^a   Cerrai, Paola ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Angiogenesis; Cooperativity; Stability; Tumour

Indexed keywords

CONSTRAINT THEORY; DRUG THERAPY; ENDOTHELIAL CELLS; PROGRAMMING THEORY;

ANGIOGENESIS; ANTI-ANGIOGENIC THERAPIES; ANTIANGIOGENESIS; BIOLOGICAL PHENOMENON; COOPERATIVITY; DYNAMICAL THEORIES; GLOBAL STABILITIES; MACROSCOPIC APPROACHES; MACROSCOPIC MODELS; MULTI-SCALE MODELLING; PARAMETRIC MODELS; STABILITY; TREATMENT RESPONSE; TUMOUR; TUMOUR GROWTHS; TWO PARAMETERS;

TUMORS;

EID: 59149085863     PISSN: 08957177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcm.2008.05.001     Document Type: Article

References (32)

1. Hahnfeldt P., Panigrahy D., Folkman J., and Hlatky L. tumour development under angiogenic signaling: A dynamical theory of tumour growth, treatment response, and postvascular dormancy. Cancer Res. 59 (1999) 4770-4775
2. Bergers G., and Benjamin L.E. Tumourigenesis and the angiogenic switch. Nat. Rev. Cancer 3 (2003) 401-410
3. Folkman J. Opinion - Angiogenesis: An organizing principle for drug discovery?. Nature Rev. Drug. Disc. 6 (2007) 273-286
4. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
5. Folkman J. Tumour angiogenesis. Adv. Cancer Res. 43 (1985) 175-203
6. Ramanujan S., Koenig G.C., Padera T.P., Stoll B.R., and Jain R.K. Local imbalance of proangiogenic and antiangiogenic factors: A potential mechanism of focal necrosis and dormancy in tumours. Cancer Res. 60 (2000) 1442-1448
7. Kerbel R.S., Yu J., Tran J., Man S., Viloria-Petit A., Klement G., Coomber B.L., and Rak J. Possible mechanisms of acquired resistance to anti-angiogenic drugs: Implications for the use of combination therapy approaches. Cancer Metastasis Rev. 20 (2001) 79-86
8. Kerbel R., and Folkman J. Clinical translation of angiogenesis inhibitors. Nature Rev. Cancer 2 (2002) 727-739
9. Kulke M.H., Bergsland E.K., Ryan D.P., Enzinger P.C., Lynch T.J., Zhu A.X., Meyerhardt J.A., Heymach J.V., Fogler W.E., Sidor C., Michelini A., Kinsella K., Venook A.P., and Fuchs C.S. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors. J. Clin. Oncol. 24 22 (2006) 3555-3561
10. Agur Z., Arakelyan L., Daugulis P., and Ginosar Y. Hopf point analysis for angiogenesis models. Discrete Contin. Dyn. Syst. B 4 (2004) 29-38
11. De Angelis E., and Preziosi L. Advection-diffusion models for solid tumour evolution in vivo and related free boundary problem. Math. Models Methods Appl. Sci. 10 (2000) 379-408
12. Alarcon T., Byrne H.M., and Maini P.K. A cellular automaton model for tumour growth in inhomogeneous environment. J. Theoret. Biol. 225 (2003) 257-274
13. Anderson A.R.A., and Chaplain M.A.J. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol. 60 (1998) 857-899
14. Stamper I.J., Byrne H.M., and Maini P.K. Modelling the role of angiogenesis and vasculogenesis in solid tumour growth. Bull. Math. Biol. 69 (2007) 2737-2772
15. Forys U., Kheifetz Y., and Kogan Y. Critical point analysis for three-variable cancer angiogenesis models. Math. Biosci. Eng. 2 (2005) 511-525
16. Arakelyan L., Merbl Y., and Agur Z. A computer algorithm describing angiogenesis and vessel maturation and its use for studying the effects of anti-angiogenic and anti-maturation therapy on vascular tumour growth. Angiogenesis 5 (2002) 203-214
17. Arakelyan L., Merbl Y., and Agur Z. Vessel maturation effects on tumour growth: Computer model validated in implanted human ovarian carcinoma spheroids. Eur. J. Cancer 41 (2005) 159-167
18. Tee D., and DiStefano III J. Simulation of tumour-induced angiogenesis and its response to anti-angiogenic drug treatment: Mode of drug delivery and clearance rate dependencies. J. Cancer Res. Clin. Oncol. 130 (2004) 15-24
19. McDougall S.R., Anderson A.R.A., and Chaplain M.A.J. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies. J. Theoret. Biol. 241 (2006) 564-589
20. d'Onofrio A., and Gandolfi A. Tumour eradication by antiangiogenic therapy: Analysis and extensions of the model by Hahnfeldt et al. (1999). Math. Biosci. 191 (2004) 159-184
21. d'Onofrio A., and Gandolfi A. The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation. Appl. Math. Comput. 181 (2006) 1155-1162
22. Ergun A., Camphausen K., and Wein L.M. Optimal scheduling of radiotherapy and angiogenic inhibitors. Bull. Math. Biol. 65 (2003) 407-424
23. A. d'Onofrio, A. Gandolfi, A. Rocca, The dynamics of tumour-vasculature interaction suggests low-dose, time-dense antiangiogenic schedulings, Cell Proliferation (2008) (in press)
24. Drixler T.A., Borel Rinkes I.H.M., Ritchie E.D., van Vroonhoven T.J.M.V., Gebbink M.F.B.G., and Voest E.E. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res. 60 (2000) 1761-1765
25. O'Donnell A., Padhani A., and Hayes F. A Phase I trial of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points. Br. J. Cancer 93 (2005) 876-883
26. Ledzewicz U., and Schättler H. Anti-angiogenic therapy in cancer treatment as an optimal control problem. SIAM J. Control. Optim. 46 (2007) 1053-1079
27. Swierniak A., d'Onofrio A., and Gandolfi A. Control problems related to tumour angiogenesis. Proceeding of IECON 2006 (2006), IEEE Press 677-681
28. Sachs R.K., Hlatky L.R., and Hahnfeldt P. Simple ODE models of tumour growth and anti-angiogenic or radiation treatment. Math. Comput. Modelling 33 (2001) 1297-1305
29. A. d'Onofrio, A. Gandolfi, A. Rocca, 2007 (submitted for publication)
30. Arakelyan L., Merbl Y., Daugulis P., Ginosar Y., Vainstein V., Selister V., Kogan Y., Harpak H., and Agur Z. Multi-scale analysis of angiogenic dynamics and therapy. In: Preziosi L. (Ed). Cancer Modelling and Simulation (2003), CRC Press, LLC, UK
31. Bellomo N. Modelling Complex Living Systems. A Kinetic Theory and Stochastic Game Approach (2008), Birkhauser-Springer, Boston
32. Bellomo N., Lin N.K., and Maini P.K. On the foundations of cancer modelling: Selected topics, speculation and perspectives. Math. Models Methods Appl. Sci. 18 (2008) 1-54